{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:52:05Z","timestamp":1777506725767,"version":"3.51.4"},"reference-count":198,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.bbalip.2014.02.008","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T16:30:49Z","timestamp":1393950649000},"page":"1189-1199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["From sheep to mice to cells: Tools for the study of the sphingolipidoses"],"prefix":"10.1016","volume":"1841","author":[{"given":"Hila","family":"Zigdon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Meshcheriakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony H.","family":"Futerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2014.02.008_bb0005","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1007\/s00018-007-7076-0","article-title":"The metabolism and function of sphingolipids and glycosphingolipids","volume":"64","author":"Lahiri","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0010","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrm1423","article-title":"The cell biology of lysosomal storage disorders","volume":"5","author":"Futerman","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0015","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12017-010-8133-7","article-title":"Pathology and current treatment of neurodegenerative sphingolipidoses","volume":"12","author":"Eckhardt","year":"2010","journal-title":"Neruomol. Med."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.semcdb.2004.03.003","article-title":"The pathogenesis of glycosphingolipid storage disorders","volume":"15","author":"Ginzburg","year":"2004","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.bi.60.070191.001353","article-title":"Lysosomal storage diseases","volume":"60","author":"Neufeld","year":"1991","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0030","doi-asserted-by":"crossref","first-page":"20423","DOI":"10.1074\/jbc.R110.134452","article-title":"Common and uncommon pathogenic cascades in lysosomal storage diseases","volume":"285","author":"Vitner","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0035","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/hmg\/ddp061","article-title":"No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease","volume":"18","author":"Farfel-Becker","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0040","first-page":"399","article-title":"Anderson\u2013Fabry disease (angiokeratoma corporis diffusum universale)","volume":"66","author":"Radcliffe","year":"1990","journal-title":"Genitourin. Med."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0045","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0050","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.braindev.2003.09.006","article-title":"Sphingolipidoses in Turkey","volume":"26","author":"Ozkara","year":"2004","journal-title":"Brain Dev."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0055","series-title":"U Patterson, DF, animal models of lysosomal storage diseases: their development and clinical relevance","author":"Haskins","year":"2006"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0060","series-title":"Gaucher Disease","author":"Futerman","year":"2006"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0065","doi-asserted-by":"crossref","first-page":"e57560","DOI":"10.1371\/journal.pone.0057560","article-title":"Substrate compositional variation with tissue\/region and Gba1 mutations in mouse models\u2014implications for Gaucher disease","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0070","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1399-0004.2007.00899.x","article-title":"Non-neuronopathic Gaucher disease due to saposin C deficiency","volume":"72","author":"Tylki-Szymanska","year":"2007","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0075","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2012.04.024","article-title":"The role of saposin C in Gaucher disease","volume":"106","author":"Tamargo","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1096\/fasebj.5.3.2001789","article-title":"Saposin proteins: structure, function, and role in human lysosomal storage disorders","volume":"5","author":"O'Brien","year":"1991","journal-title":"FASEB J."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/gte.1997.1.5","article-title":"Gaucher disease: gene frequencies and genotype\/phenotype correlations","volume":"1","author":"Grabowski","year":"1997","journal-title":"Genet. Test."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0090","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/mds.23774","article-title":"Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond","volume":"26","author":"Shachar","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0095","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0100","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1242\/dmm.008185","article-title":"Animal models for Gaucher disease research","volume":"4","author":"Farfel-Becker","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0105","doi-asserted-by":"crossref","first-page":"23815","DOI":"10.1074\/jbc.M502799200","article-title":"X-ray structure of human acid-beta-glucosidase covalently bound to conduritol-B-epoxide","volume":"280","author":"Premkumar","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0006-291X(75)90286-7","article-title":"The Gaucher mouse","volume":"67","author":"Kanfer","year":"1975","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0115","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0003-9861(92)90685-P","article-title":"Inhibition of glucocerebrosidase and induction of neural abnormality by cyclophellitol in mice","volume":"297","author":"Atsumi","year":"1992","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0120","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/abbi.1993.1353","article-title":"Accumulation of tissue glucosylsphingosine in Gaucher-like mouse induced by the glucosylceramidase inhibitor cyclophellitol","volume":"304","author":"Atsumi","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ymgme.2008.01.013","article-title":"Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid beta-glucosidase residual activity levels","volume":"94","author":"Xu","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/357407a0","article-title":"Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene","volume":"357","author":"Tybulewicz","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0135","doi-asserted-by":"crossref","first-page":"17483","DOI":"10.1073\/pnas.0708086104","article-title":"Murine models of acute neuronopathic Gaucher disease","volume":"104","author":"Enquist","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0140","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/hmg\/ddt468","article-title":"Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration","volume":"23","author":"Farfel-Becker","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0145","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/hmg\/ddr019","article-title":"Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease","volume":"20","author":"Farfel-Becker","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0150","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1093\/hmg\/ddq273","article-title":"Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease and in other sphingolipidoses","volume":"19","author":"Vitner","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0155","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/brain\/aws095","article-title":"Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease","volume":"135","author":"Vitner","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0160","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm.3449","article-title":"RIP3 as a novel potential therapeutic target for Gaucher disease","volume":"20","author":"Vitner","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0165","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease","volume":"163","author":"Xu","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0170","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1073\/pnas.95.5.2503","article-title":"Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure","volume":"95","author":"Liu","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0175","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI0214530","article-title":"Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage","volume":"109","author":"Mizukami","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0180","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"Mistry","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0185","doi-asserted-by":"crossref","first-page":"13819","DOI":"10.1073\/pnas.0606016103","article-title":"Effective cell and gene therapy in a murine model of Gaucher disease","volume":"103","author":"Enquist","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0190","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2006.09.008","article-title":"Generation of a conditional knockout of murine glucocerebrosidase: utility for the study of Gaucher disease","volume":"90","author":"Sinclair","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0195","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF03402150","article-title":"A chimeric mouse model of Gaucher disease","volume":"8","author":"Beutler","year":"2002","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0200","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/hmg\/ddp531","article-title":"Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouse","volume":"19","author":"Sun","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0205","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1096-7192(02)00114-2","article-title":"Prosaposin: threshold rescue and analysis of the \u201cneuritogenic\u201d region in transgenic mice","volume":"76","author":"Sun","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0210","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1194\/jlr.M500202-JLR200","article-title":"Gaucher disease mouse models: point mutations at the acid beta-glucosidase locus combined with low-level prosaposin expression lead to disease variants","volume":"46","author":"Sun","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0215","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.22400","article-title":"Acid beta-glucosidase mutants linked to Gaucher disease. Parkinson disease, and Lewy body dementia alter alpha-synuclein processing","volume":"69","author":"Cullen","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0220","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1194\/jlr.M600239-JLR200","article-title":"Conditional expression of human acid beta-glucosidase improves the visceral phenotype in a Gaucher disease mouse model","volume":"47","author":"Sun","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0225","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bcmd.2013.03.006","article-title":"Transgenic mice expressing human glucocerebrosidase variants: utility for the study of Gaucher disease","volume":"51","author":"Sanders","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0230","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/030098587301000302","article-title":"Neurovisceral glucocerebroside storage (Gaucher's disease) in a dog","volume":"10","author":"Hartley","year":"1973","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0235","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/path.1711000310","article-title":"Histiocytosis in two pigs and a cow: conditions resembling lipid storage disorders in man","volume":"100","author":"Sandison","year":"1970","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0240","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1751-0813.1968.tb09137.x","article-title":"Lipidosis of the hepatic reticulo-endothelial cells in a sheep","volume":"44","author":"Laws","year":"1968","journal-title":"Aust. Vet. J."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0245","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10545-010-9230-3","article-title":"Gaucher disease in sheep","volume":"34","author":"Karageorgos","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0250","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ymgme.2007.08.001","article-title":"Secondary sphingolipid accumulation in a macrophage model of Gaucher disease","volume":"92","author":"Hein","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0255","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bcmd.2005.07.009","article-title":"Recombinant glucocerebrosidase uptake by Gaucher disease human osteoblast culture model","volume":"35","author":"Lamghari","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0260","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1005622001239","article-title":"The increased sensitivity of neurons with elevated glucocerebroside to neurotoxic agents can be reversed by imiglucerase","volume":"23","author":"Pelled","year":"2000","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0265","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/(SICI)1097-4547(19960201)43:3<365::AID-JNR11>3.0.CO;2-4","article-title":"In vitro accumulation of glucocerebroside in neuroblastoma cells: a model for study of Gaucher disease pathobiology","volume":"43","author":"Prence","year":"1996","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0270","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bcmd.2007.03.005","article-title":"Changes in macrophage morphology in a Gaucher disease model are dependent on CTP: phosphocholine cytidylyltransferase alpha","volume":"39","author":"Kacher","year":"2007","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0275","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bcmd.2004.03.001","article-title":"Phosphatidylcholine metabolism is altered in a monocyte-derived macrophage model of Gaucher disease but not in lymphocytes","volume":"33","author":"Trajkovic-Bodennec","year":"2004","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0280","first-page":"40","article-title":"Glucocerebroside storage in normal monocyte cultures","volume":"41","author":"Hardy","year":"1987","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0285","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.nbd.2003.08.016","article-title":"Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3","volume":"14","author":"Schueler","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0290","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1042\/bj20030613","article-title":"Lyso-glycosphingolipids mobilize calcium from brain microsomes via multiple mechanisms","volume":"375","author":"Lloyd-Evans","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0295","doi-asserted-by":"crossref","first-page":"18054","DOI":"10.1073\/pnas.1207889109","article-title":"Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease","volume":"109","author":"Panicker","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0300","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1101\/gad.981002","article-title":"Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells","volume":"16","author":"Paddison","year":"2002","journal-title":"Genes Dev"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0305","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s100380170088","article-title":"Fabry disease: twenty novel alpha-galactosidase A mutations causing the classical phenotype","volume":"46","author":"Ashley","year":"2001","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0310","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/humu.1380030204","article-title":"Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene","volume":"3","author":"Eng","year":"1994","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0315","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jbspin.2003.10.015","article-title":"Fabry disease: a review","volume":"71","author":"Masson","year":"2004","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0320","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","article-title":"Alpha-galactosidase A deficient mice: a model of Fabry disease","volume":"94","author":"Ohshima","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0325","doi-asserted-by":"crossref","first-page":"e33743","DOI":"10.1371\/journal.pone.0033743","article-title":"Cardiomyopathy and response to enzyme replacement therapy in a male mouse model for Fabry disease","volume":"7","author":"Nguyen Dinh Cat","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0330","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2008.09.001","article-title":"Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice","volume":"33","author":"Rodrigues","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0335","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00428-011-1051-8","article-title":"Kidney histologic alterations in alpha-Galactosidase-deficient mice","volume":"458","author":"Valbuena","year":"2011","journal-title":"Virchows Arch."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0340","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0014-5793(97)01263-5","article-title":"Generation and characterization of transgenic mice expressing a human mutant alpha-galactosidase with an R301Q substitution causing a variant form of Fabry disease","volume":"417","author":"Shimmoto","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0345","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bbadis.2004.07.001","article-title":"Transgenic mouse expressing human mutant alpha-galactosidase A in an endogenous enzyme deficient background: a biochemical animal model for studying active-site specific chaperone therapy for Fabry disease","volume":"1690","author":"Ishii","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0350","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ki.2008.576","article-title":"Downregulation of alpha-galactosidase A upregulates CD77: functional impact for Fabry nephropathy","volume":"75","author":"Thomaidis","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0355","doi-asserted-by":"crossref","first-page":"e63506","DOI":"10.1371\/journal.pone.0063506","article-title":"Dysregulated autophagy contributes to podocyte damage in Fabry's disease","volume":"8","author":"Liebau","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0360","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ymgme.2007.06.003","article-title":"Establishment and characterization of Fabry disease endothelial cells with an extended lifespan","volume":"92","author":"Shen","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0365","doi-asserted-by":"crossref","first-page":"7886","DOI":"10.1073\/pnas.1002758107","article-title":"Induced pluripotent stem cells derived from mouse models of lysosomal storage disorders","volume":"107","author":"Meng","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0370","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/08830738030180090301","article-title":"Metachromatic leukodystrophy: recent research developments","volume":"18","author":"Gieselmann","year":"2003","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0375","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ajmg.a.32712","article-title":"Prosaposin deficiency and saposin B deficiency (activator-deficient metachromatic leukodystrophy): report on two patients detected by analysis of urinary sphingolipids and carrying novel PSAP gene mutations","volume":"149A","author":"Kuchar","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0380","doi-asserted-by":"crossref","first-page":"E220","DOI":"10.1002\/humu.20851","article-title":"Molecular analysis of ARSA and PSAP genes in twenty-one Italian patients with metachromatic leukodystrophy: identification and functional characterization of 11 novel ARSA alleles","volume":"29","author":"Grossi","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0385","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1023\/A:1005471106088","article-title":"Metachromatic leukodystrophy: molecular genetics and an animal model","volume":"21","author":"Gieselmann","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0390","doi-asserted-by":"crossref","first-page":"14821","DOI":"10.1073\/pnas.93.25.14821","article-title":"Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy","volume":"93","author":"Hess","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0395","doi-asserted-by":"crossref","first-page":"9482","DOI":"10.1523\/JNEUROSCI.2287-07.2007","article-title":"Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy","volume":"27","author":"Ramakrishnan","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0400","doi-asserted-by":"crossref","first-page":"9009","DOI":"10.1523\/JNEUROSCI.2329-07.2007","article-title":"Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy","volume":"27","author":"Eckhardt","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0405","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/hmg\/ddi126","article-title":"Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy","volume":"14","author":"Matzner","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0410","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2119\/2007-00063Matzner","article-title":"Induction of tolerance to human arylsulfatase A in a mouse model of metachromatic leukodystrophy","volume":"13","author":"Matzner","year":"2007","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0415","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/hmg\/dds086","article-title":"Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age","volume":"21","author":"Matthes","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0420","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1093\/hmg\/ddr175","article-title":"Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy","volume":"20","author":"Stroobants","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0425","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1093\/hmg\/ddn135","article-title":"Neurological deficits and glycosphingolipid accumulation in saposin B deficient mice","volume":"17","author":"Sun","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0430","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jneumeth.2006.11.009","article-title":"A spontaneously immortalized Schwann cell line to study the molecular aspects of metachromatic leukodystrophy","volume":"161","author":"Saravanan","year":"2007","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0435","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/hmg\/10.11.1191","article-title":"A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse","volume":"10","author":"Matsuda","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0440","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/B978-0-444-59565-2.00029-0","article-title":"Lysosomal leukodystrophies: Krabbe disease and metachromatic leukodystrophy","volume":"113","author":"Kohlschutter","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0445","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s13311-011-0080-y","article-title":"The myelin mutants as models to study myelin repair in the leukodystrophies","volume":"8","author":"Duncan","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0450","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.braindev.2009.03.001","article-title":"Pathogenesis of leukodystrophy for Krabbe disease: molecular mechanism and clinical treatment","volume":"31","author":"Sakai","year":"2009","journal-title":"Brain Dev."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0455","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/brain\/103.3.695","article-title":"Hereditary leucodystrophy in the mouse: the new mutant twitcher","volume":"103","author":"Duchen","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0460","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0006-8993(80)90159-6","article-title":"The twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease)","volume":"202","author":"Kobayashi","year":"1980","journal-title":"Brain Res."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0465","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/0006-291X(82)91987-8","article-title":"An accumulation of galactocerebroside in kidney from mouse globoid cell leukodystrophy (twitcher)","volume":"109","author":"Ida","year":"1982","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0470","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1093\/hmg\/ddt190","article-title":"Missense mutation in mouse GALC mimics human gene defect and offers new insights into Krabbe disease","volume":"22","author":"Potter","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0475","doi-asserted-by":"crossref","first-page":"E1894","DOI":"10.1002\/humu.21367","article-title":"Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease","volume":"31","author":"Tappino","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0480","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/mgme.2001.3194","article-title":"Generation of a mouse with low galactocerebrosidase activity by gene targeting: a new model of globoid cell leukodystrophy (Krabbe disease)","volume":"73","author":"Luzi","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0485","first-page":"375","article-title":"Animal model: globoid cell leukodystrophy in the dog","author":"Fletcher","year":"1972","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0490","first-page":"303","article-title":"Globoid cell leukodystrophy in the bluetick hound dog. 1. Clinical manifestations","volume":"15","author":"Boysen","year":"1974","journal-title":"Can. Vet. J."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0495","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1006\/geno.1996.0220","article-title":"Cloning of the canine GALC cDNA and identification of the mutation causing globoid cell leukodystrophy in West Highland White and Cairn terriers","volume":"33","author":"Victoria","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0500","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/jhered\/90.1.138","article-title":"Globoid cell leukodystrophy in cairn and West Highland white terriers","volume":"90","author":"Wenger","year":"1999","journal-title":"J. Hered."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0505","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1006\/geno.1997.4744","article-title":"Characterization of the rhesus monkey galactocerebrosidase (GALC) cDNA and gene and identification of the mutation causing globoid cell leukodystrophy (Krabbe disease) in this primate","volume":"42","author":"Luzi","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0510","first-page":"476","article-title":"Genetic galactocerebrosidase deficiency (globoid cell leukodystrophy, Krabbe disease) in rhesus monkeys (Macaca mulatta)","volume":"48","author":"Baskin","year":"1998","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0515","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2353\/ajpath.2008.070404","article-title":"Clinical and immunopathologic alterations in rhesus macaques affected with globoid cell leukodystrophy","volume":"172","author":"Borda","year":"2008","journal-title":"The American journal of pathology"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0520","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/030098588001700402","article-title":"Globoid cell leucodystrophy in polled Dorset sheep","volume":"17","author":"Pritchard","year":"1980","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0525","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jcpa.2004.12.001","article-title":"Clinicopathological features of globoid cell leucodystrophy in cats","volume":"132","author":"Salvadori","year":"2005","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0530","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1354\/vp.39-4-494","article-title":"Globoid cell-like leukodystrophy in a domestic longhaired cat","volume":"39","author":"Sigurdson","year":"2002","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0535","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/ilar.50.2.112","article-title":"Gene therapy for lysosomal storage diseases (LSDs) in large animal models","volume":"50","author":"Haskins","year":"2009","journal-title":"ILAR J."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0540","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1022436928925","article-title":"Twenty five years of the \u201cpsychosine hypothesis\u201d: a personal perspective of its history and present status","volume":"23","author":"Suzuki","year":"1998","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0545","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1523\/JNEUROSCI.5597-08.2009","article-title":"Psychosine accumulates in membrane microdomains in the brain of krabbe patients, disrupting the raft architecture","volume":"29","author":"White","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0550","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1194\/jlr.M600084-JLR200","article-title":"Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death","volume":"47","author":"Giri","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0555","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.6183745","article-title":"Fast axonal transport in extruded axoplasm from squid giant axon","volume":"218","author":"Brady","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0560","doi-asserted-by":"crossref","first-page":"10048","DOI":"10.1523\/JNEUROSCI.0217-13.2013","article-title":"The sphingolipid psychosine inhibits fast axonal transport in Krabbe disease by activation of GSK3-\u03b2 and deregulation of molecular motors","volume":"33","author":"Cantuti Castelvetri","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0565","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.nbd.2012.01.013","article-title":"Psychosine induces the dephosphorylation of neurofilaments by deregulation of PP1 and PP2A phosphatases","volume":"46","author":"Cantuti-Castelvetri","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0570","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.febslet.2009.11.083","article-title":"Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann\u2013Pick disease","volume":"584","author":"Schuchman","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0575","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000112332","article-title":"Partial enzyme deficiencies: residual activities and the development of neurological disorders","volume":"6","author":"Conzelmann","year":"1983","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0580","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s10545-007-0632-9","article-title":"The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann\u2013Pick disease","volume":"30","author":"Schuchman","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0585","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbalip.2004.08.012","article-title":"Before the loss: neuronal dysfunction in Niemann\u2013Pick type C disease","volume":"1685","author":"Paul","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0590","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/nm.1876","article-title":"Niemann\u2013Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium","volume":"14","author":"Lloyd-Evans","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0595","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0092-8674(05)80010-8","article-title":"Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann\u2013Pick disease)","volume":"81","author":"Otterbach","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0600","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0344-0338(97)80025-8","article-title":"Pathology of visceral organs and bone marrow in an acid sphingomyelinase deficient knock-out mouse line, mimicking human Niemann\u2013Pick disease type A A light and electron microscopic study","volume":"193","author":"Kuemmel","year":"1997","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0605","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/ng0795-288","article-title":"Acid sphingomyelinase deficient mice: a model of types A and B Niemann Pick disease","volume":"10","author":"Horinouchi","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0610","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.expneurol.2008.07.026","article-title":"Neuropathology of the acid sphingomyelinase knockout mouse model of Niemann\u2013Pick A disease including structure-function studies associated with cerebellar Purkinje cell degeneration","volume":"214","author":"Macauley","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0615","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/j.1471-4159.2005.03534.x","article-title":"Defective calcium homeostasis in the cerebellum in a mouse model of Niemann\u2013Pick A disease","volume":"95","author":"Ginzburg","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0620","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1126\/science.1060191","article-title":"Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice","volume":"293","author":"Paris","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0625","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0092-8674(00)80091-4","article-title":"Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis","volume":"86","author":"Santana","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0630","doi-asserted-by":"crossref","first-page":"44976","DOI":"10.1074\/jbc.M106455200","article-title":"Acid sphingomyelinase-deficient macrophages have defective cholesterol trafficking and efflux","volume":"276","author":"Leventhal","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0635","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.canlet.2003.08.034","article-title":"Ceramide synthesis and metabolism as a target for cancer therapy","volume":"206","author":"Reynolds","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0640","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/hmg\/9.13.1967","volume":"9","author":"Marathe","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0645","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/030098587901600504","article-title":"Niemann\u2013Pick disease in a poodle dog","volume":"16","author":"Bundza","year":"1979","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0650","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jcpa.2013.01.011","article-title":"Sphingomyelin lipidosis (Niemann\u2013Pick disease) in a juvenile raccoon (Procyon lotor)","volume":"149","author":"Vapniarsky","year":"2013","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0655","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1354\/vp.45-2-201","article-title":"Sphingomyelinase deficiency (Niemann\u2013Pick disease) in a Hereford calf","volume":"45","author":"Saunders","year":"2008","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0660","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/030098588702400504","article-title":"Sphingomyelin lipidosis in a cat","volume":"24","author":"Baker","year":"1987","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0665","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/BF00690467","article-title":"Sphingomyelin lipidosis in a cat: Golgi studies","volume":"65","author":"Walkley","year":"1984","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0670","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1126\/science.7189903","article-title":"Niemann\u2013Pick disease: a genetic model in Siamese cats","volume":"200","author":"Wenger","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0675","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-3-7091-1368-4_4","article-title":"Acid sphingomyelinase","author":"Henry","year":"2013","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0680","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.febslet.2009.11.083","article-title":"Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann\u2013Pick disease","volume":"584","author":"Schuchman","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000315100","article-title":"Small molecule inhibitors of acid sphingomyelinase","volume":"26","author":"Arenz","year":"2010","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0690","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1476-5381.2011.01279.x","article-title":"Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases","volume":"163","author":"Canals","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0695","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/emmm.201302781","article-title":"Farber disease: understanding a fatal childhood disorder and dissecting ceramide biology","volume":"5","author":"Sands","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0700","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1546-0096-5-15","article-title":"Farber disease: clinical presentation, pathogenesis and a new approach to treatment","volume":"5","author":"Ehlert","year":"2007","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0705","doi-asserted-by":"crossref","DOI":"10.1007\/8904_2013_246","article-title":"Accumulation of ordered ceramide-cholesterol domains in Farber disease fibroblasts","author":"Ferreira","year":"2013","journal-title":"JIMD Rep."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0710","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1006\/geno.2002.6686","article-title":"Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes","volume":"79","author":"Li","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0715","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/emmm.201202301","article-title":"Systemic ceramide accumulation leads to severe and varied pathological consequences","volume":"5","author":"Alayoubi","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0720","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2174\/138945008785132358","article-title":"Molecular targeting of acid ceramidase: implications to cancer therapy","volume":"9","author":"Zeidan","year":"2008","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0725","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1159\/000341453","article-title":"Construction of conditional acid ceramidase knockout mice and in vivo effects on oocyte development and fertility","volume":"30","author":"Eliyahu","year":"2012","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0730","first-page":"1233","article-title":"Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer","volume":"61","author":"Selzner","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0735","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ymgme.2008.04.012","article-title":"GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects","volume":"94","author":"Brunetti-Pierri","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0740","doi-asserted-by":"crossref","first-page":"10195","DOI":"10.1523\/JNEUROSCI.0822-13.2013","article-title":"Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis","volume":"33","author":"Sandhoff","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0745","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbadis.2011.03.018","article-title":"GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings","volume":"1812","author":"Caciotti","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0750","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/hmg\/6.2.205","article-title":"Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid beta-galactosidase","volume":"6","author":"Hahn","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0755","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1023\/A:1018573518127","article-title":"Beta-galactosidase-deficient mouse as an animal model for GM1-gangliosidosis","volume":"14","author":"Matsuda","year":"1997","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0760","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ymgme.2008.02.005","article-title":"Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis","volume":"94","author":"Elliot-Smith","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0765","doi-asserted-by":"crossref","first-page":"e13468","DOI":"10.1371\/journal.pone.0013468","article-title":"AAV-mediated gene delivery in adult GM1-gangliosidosis mice corrects lysosomal storage in CNS and improves survival","volume":"5","author":"Baek","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0770","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.molcel.2009.10.021","article-title":"GM1-ganglioside accumulation at the mitochondria-associated ER membranes links ER stress to Ca2+-dependent mitochondrial apoptosis","volume":"36","author":"Sano","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0775","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1073\/pnas.2536657100","article-title":"Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis","volume":"100","author":"Matsuda","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0780","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/vr.146.17.493","article-title":"GM1 gangliosidosis in shiba dogs","volume":"146","author":"Yamato","year":"2000","journal-title":"Vet. Rec."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0785","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1023\/A:1005630013448","article-title":"Isolation and characterization of the normal canine beta-galactosidase gene and its mutation in a dog model of GM1-gangliosidosis","volume":"23","author":"Wang","year":"2000","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0790","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0887-8994(92)90361-2","article-title":"Dysmyelinogenesis in animal model of GM1 gangliosidosis","volume":"8","author":"Kaye","year":"1992","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0795","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1354\/vp.38-3-281","article-title":"GM1-gangliosidosis in Alaskan huskies: clinical and pathologic findings","volume":"38","author":"Muller","year":"2001","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0800","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1177\/1098612X12454120","article-title":"Mutation analysis of GM1 gangliosidosis in a Siamese cat from Japan in the 1960s","volume":"14","author":"Uddin","year":"2012","journal-title":"J. Feline Med. Surg."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0805","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s004010050899","article-title":"Beta-galactosidase deficiency in a Korat cat: a new form of feline GM1-gangliosidosis","volume":"96","author":"De Maria","year":"1998","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0810","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s004010000267","article-title":"A lysosomal storage disease of Romney sheep that resembles human type 3 GM1 gangliosidosis","volume":"101","author":"Ryder","year":"2001","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0815","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/030098589102800410","article-title":"Similarity of lectin histochemistry of a lysosomal storage disease in a New Zealand lamb to that of ovine GM1 gangliosidosis","volume":"28","author":"Murnane","year":"1991","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0820","first-page":"755","article-title":"Ultrastructural lesions of ovine GM1 gangliosidosis","volume":"4","author":"Murnane","year":"1991","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0825","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/vr.100.15.318","article-title":"Leukocyte beta-galactosidase activity in the diagnosis of bovine GM1 gangliosidosis","volume":"100","author":"Donnelly","year":"1977","journal-title":"Vet. Rec."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0830","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/path.1711110305","article-title":"GM1 gangliosidosis in Friesian calves","volume":"111","author":"Donnelly","year":"1973","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0835","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1746-6148-9-132","article-title":"Molecular epidemiology of canine GM1 gangliosidosis in the Shiba Inu breed in Japan: relationship between regional prevalence and carrier frequency","volume":"9","author":"Uddin","year":"2013","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0840","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00192635","article-title":"Retarded bone formation in GM1-gangliosidosis: a study of the infantile form and comparison with two canine models","volume":"426","author":"Alroy","year":"1995","journal-title":"Virchows Arch."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0845","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1042\/bj2350151","article-title":"GM1 gangliosidosis (type 1) in a cat","volume":"235","author":"Barker","year":"1986","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0850","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.1582-4934.2007.00204.x","article-title":"Insights into post-translational processing of beta-galactosidase in an animal model resembling late infantile human G-gangliosidosis","volume":"12","author":"Kreutzer","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0855","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF01119596","article-title":"In vitro establishment of human fibroblasts of lysosomal diseases, GM1-gangliosidosis and Sandhoff disease, by transformation with origin-minus SV40 DNA","volume":"5","author":"Momoi","year":"1985","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0860","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/5.1.1","article-title":"Dramatically different phenotypes in mouse models of human Tay\u2013Sachs and Sandhoff diseases","volume":"5","author":"Phaneuf","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0865","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archneur.62.6.989","article-title":"The natural history of cognitive dysfunction in late-onset GM2 gangliosidosis","volume":"62","author":"Frey","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0870","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/B:BOLI.0000028777.38551.5a","article-title":"Juvenile Sandhoff disease\u2014nine new cases and a review of the literature","volume":"27","author":"Hendriksz","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0875","doi-asserted-by":"crossref","first-page":"9975","DOI":"10.1073\/pnas.91.21.9975","article-title":"Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay\u2013Sachs disease","volume":"91","author":"Yamanaka","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0880","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/BF00292433","article-title":"Disruption of murine Hexa gene leads to enzymatic deficiency and to neuronal lysosomal storage, similar to that observed in Tay\u2013Sachs disease","volume":"6","author":"Cohen-Tannoudji","year":"1995","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0885","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng1095-170","article-title":"Mouse models of Tay\u2013Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism","volume":"11","author":"Sango","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0890","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1073\/pnas.94.15.8138","article-title":"Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment","volume":"94","author":"Liu","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0895","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1023\/A:1005419122018","article-title":"Glycosphingolipid degradation and animal models of GM2-gangliosidoses","volume":"21","author":"Kolter","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0900","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ymgme.2008.06.010","article-title":"Spontaneous appearance of Tay\u2013Sachs disease in an animal model","volume":"95","author":"Zeng","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0905","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/nbdi.2002.0511","article-title":"An inducible mouse model of late onset Tay\u2013Sachs disease","volume":"10","author":"Jeyakumar","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0910","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.brainres.2003.11.067","article-title":"Late onset Tay\u2013Sachs disease in mice with targeted disruption of the Hexa gene: behavioral changes and pathology of the central nervous system","volume":"1001","author":"Miklyaeva","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0915","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/ng1196-348","article-title":"Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis","volume":"14","author":"Sango","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0920","doi-asserted-by":"crossref","first-page":"e1002943","DOI":"10.1371\/journal.pgen.1002943","article-title":"Characterization of inducible models of Tay\u2013Sachs and related disease","volume":"8","author":"Sargeant","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0925","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1471-4159.1987.tb05596.x","article-title":"Biochemical basis of type AB GM2 gangliosidosis in a Japanese spaniel","volume":"48","author":"Ishikawa","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0930","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ymgme.2012.11.008","article-title":"GM2 gangliosidosis associated with a HEXA missense mutation in Japanese Chin dogs: a potential model for Tay Sachs disease","volume":"108","author":"Sanders","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0935","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1023\/A:1016562626961","article-title":"Sandhoff disease in a golden retriever dog","volume":"25","author":"Yamato","year":"2002","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0940","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jfms.2006.11.003","article-title":"Clinical and molecular analysis of GM2 gangliosidosis in two apparent littermate kittens of the Japanese domestic cat","volume":"9","author":"Hasegawa","year":"2007","journal-title":"J. Feline Med. Surg."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0945","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.rvsc.2006.05.007","article-title":"Nonsense mutation of feline beta-hexosaminidase beta-subunit (HEXB) gene causing Sandhoff disease in a family of Japanese domestic cats","volume":"82","author":"Kanae","year":"2007","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0950","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/030098587801500601","article-title":"Clinical and biochemical abnormalities in porcine GM2-gangliosidosis","volume":"15","author":"Kosanke","year":"1978","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0955","first-page":"419","article-title":"Animal model of human disease: GM2 gangliosidosis","volume":"83","author":"Pierce","year":"1976","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0960","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s004010050955","article-title":"Naturally occurring GM2 gangliosidosis in two Muntjak deer with pathological and biochemical features of human classical Tay\u2013Sachs disease (type B GM2 gangliosidosis)","volume":"97","author":"Fox","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0965","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ymgme.2010.08.006","article-title":"Tay\u2013Sachs disease in Jacob sheep","volume":"101","author":"Torres","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0970","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jcpa.2012.06.008","article-title":"GM2 gangliosidosis in an adult pet rabbit","volume":"148","author":"Rickmeyer","year":"2013","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.bbalip.2014.02.008_bb0975","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0140-6736(95)92590-2","article-title":"Bone marrow transplantation for lysosomal diseases","volume":"345","author":"Walkley","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0980","first-page":"1109","article-title":"Characterization of the molecular defect in a feline model for type II GM2-gangliosidosis (Sandhoff disease)","volume":"144","author":"Muldoon","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0985","doi-asserted-by":"crossref","first-page":"e55856","DOI":"10.1371\/journal.pone.0055856","article-title":"Impaired neural differentiation of induced pluripotent stem cells generated from a mouse model of Sandhoff disease","volume":"8","author":"Ogawa","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2014.02.008_bb0990","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1073\/pnas.96.11.6423","article-title":"Aging accentuates and bone marrow transplantation ameliorates metabolic defects in Fabry disease mice","volume":"96","author":"Ohshima","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198114000353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198114000353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T00:41:18Z","timestamp":1597538478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198114000353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":198,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1388198114000353"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2014.02.008","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From sheep to mice to cells: Tools for the study of the sphingolipidoses","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2014.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}